Clinical Trial: Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

Brief Summary: To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of side effects as reported by patients at their visits and by frequent monitoring of hematology, biochemistries, and urinalysis.

Detailed Summary:
Sponsor: Janssen, LP

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: NIH AIDS Clinical Trials Information Service

Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: June 23, 2005
Last Verified: June 1990